Tudor Investment Corp ET AL trimmed its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 72.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,125 shares of the business services provider's stock after selling 188,421 shares during the period. Tudor Investment Corp ET AL's holdings in Genpact were worth $3,063,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the business. Principal Financial Group Inc. raised its stake in Genpact by 36.3% in the third quarter. Principal Financial Group Inc. now owns 497,105 shares of the business services provider's stock valued at $20,824,000 after buying an additional 132,310 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Genpact by 17.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,762,407 shares of the business services provider's stock worth $157,609,000 after acquiring an additional 549,117 shares during the period. Envestnet Asset Management Inc. increased its holdings in shares of Genpact by 64.3% during the 3rd quarter. Envestnet Asset Management Inc. now owns 533,566 shares of the business services provider's stock worth $22,351,000 after acquiring an additional 208,762 shares during the last quarter. ProShare Advisors LLC increased its holdings in shares of Genpact by 27.5% during the 3rd quarter. ProShare Advisors LLC now owns 153,260 shares of the business services provider's stock worth $6,420,000 after acquiring an additional 33,056 shares during the last quarter. Finally, Allianz Asset Management GmbH increased its holdings in shares of Genpact by 153.6% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,597,446 shares of the business services provider's stock worth $66,917,000 after acquiring an additional 967,559 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Genpact
In other news, SVP Riju Vashisht sold 16,016 shares of the firm's stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $46.65, for a total transaction of $747,146.40. Following the transaction, the senior vice president directly owned 95,521 shares of the company's stock, valued at approximately $4,456,054.65. This trade represents a 14.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 2,800 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total transaction of $114,156.00. Following the transaction, the chief executive officer directly owned 525,007 shares in the company, valued at $21,404,535.39. This represents a 0.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 33,904 shares of company stock valued at $1,565,158. 1.58% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the company. Mizuho decreased their target price on Genpact from $51.00 to $49.00 and set a "neutral" rating on the stock in a report on Tuesday, February 10th. Susquehanna set a $42.00 target price on Genpact in a report on Friday, February 6th. Weiss Ratings reissued a "hold (c+)" rating on shares of Genpact in a report on Friday, December 26th. Wall Street Zen lowered Genpact from a "buy" rating to a "hold" rating in a report on Saturday, March 14th. Finally, Needham & Company LLC decreased their target price on Genpact from $53.00 to $50.00 and set a "buy" rating on the stock in a report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $47.29.
Get Our Latest Analysis on Genpact
Genpact Stock Down 3.8%
Genpact stock opened at $34.19 on Friday. The stock has a market cap of $5.80 billion, a P/E ratio of 10.92, a P/E/G ratio of 1.05 and a beta of 0.74. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.46. Genpact Limited has a twelve month low of $33.92 and a twelve month high of $50.41. The company's 50-day moving average price is $38.43 and its two-hundred day moving average price is $42.01.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Friday, February 6th. The business services provider reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. The firm had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.31 billion. Genpact had a net margin of 10.88% and a return on equity of 22.02%. The business's revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 EPS. As a group, analysts expect that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Monday, March 16th were issued a dividend of $0.1875 per share. This is a boost from Genpact's previous quarterly dividend of $0.17. This represents a $0.75 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Monday, March 16th. Genpact's payout ratio is 23.96%.
Genpact Profile
(
Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report